Prevail Therapeutics Inc.

Point72 Asset Management, L.P.

Report date

9/30/2020

Quarter

2020 Q3

Filed

11/16/2020

Shares

157,335

Value ($000)

1,602

Weight

0.0%

2019 Q4 - 2020 Q3 (3 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2020 Q3	11/16/2020	1,602	0.0%	157,335	9/30/2020
2020 Q1	5/15/2020	528	0.0%	43,347	3/31/2020
2019 Q4	2/14/2020	5,799	0.0%	366,324	12/31/2019